EMEA-003604-PIP01-24

Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Date of authorisation: 19/09/2019, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 57, Status: Authorised

EMEA-003161-PIP02-24

EMEA-003533-PIP01-23

EMEA-003532-PIP01-23

EMEA-002476-PIP03-24

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Kirsty (previously Kixelle), insulin aspart, Date of authorisation: 05/02/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Lysodren, mitotane, Date of authorisation: 28/04/2004, Revision: 24, Status: Authorised